vimarsana.com

Page 11 - முதுமறதி சங்கம் சர்வதேச மாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covid-19 infection linked to long-term cognitive dysfunction: Study

Covid-19 infection linked to long-term cognitive dysfunction: Study ​ By IANS | ​ 0 Views   New York, July 30 : Covid-19 is associated with persistent cognitive deficits, including the acceleration of Alzheimer s disease pathology and symptoms, according to researchers. Experts from the US Alzheimer s Association-led global SARS-CoV-2 consortium reported the findings at the Alzheimer s Association International Conference (AAIC) 2021, held virtually and in Denver, Colorado. They revealed that older adults frequently suffer persistent cognitive impairment, including persistent lack of smell, after recovery from SARS-CoV-2 infection. Biological markers of brain injury, neuro-inflammation and Alzheimer s correlate strongly with the presence of neurological symptoms in Covid-19 patients. Individuals experiencing cognitive decline post-Covid-19 infection were also more likely to have low blood oxygen following brief physical exertion as well as poor overall physical condi

Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer s Disease at AAIC 2021

(1) - ICARE AD-US is an observational real-world phase 4 study designed to evaluate the safety and effectiveness of ADUHELM in clinical practice - ICARE AD-US is one of three programs to generate post-approval data on ADUHELM, including the re-dosing Phase 3b EMBARK study and the planned confirmatory Phase 4 post-marketing requirement study - Biogen aims to enroll at least 16 percent Latinx and Black/African American patients with Alzheimer s disease in the ICARE AD-US study as part of its commitment to increase participation from traditionally underrepresented communities TOKYO, July 30, 2021 - (JCN Newswire) - Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo) today announced that Biogen led a late-breaking presentation on the design of the first real-world observational Phase 4 study in Alzheimer s disease called ICARE AD-US, at the Alzheimer s Association International Conference (AAIC), being held both virtually and in Denver, Colorado from July 26 - 30, 2021. ICARE AD-US, a

New evidence has doctors worried about long-term damage from COVID brain fog

New evidence has doctors worried about long-term damage from COVID brain fog • 5 min read How to clear up ‘brain fog’ Dr. Kristen Willeumier gives tips on how to improve brain function and overall health while dealing with the challenges of working from home and being confined inside. Phill Magakoe/Pool via Reuters/FILE A flurry of new scientific findings is prompting renewed concern among doctors about the long-term cognitive impacts of COVID-19 in some patients. Several new studies presented at the Alzheimer s Association International Conference, being held this week in Denver, have found that many COVID-19 patients experience brain fog and other cognitive impairments months after recovery. This adds to a growing body of research on COVID-19 s apparent long-haul symptoms, which can include confusion, forgetfulness and other worrying signs of memory loss.

Post-COVID Cognitive Impairment: What New Research Suggests

Katarina Radovic/Stocksy; Adobe Stock Two studies presented at the 2021 Alzheimer’s Association International Conference (AAIC) in Denver suggest that COVID-19 may lead to cognitive impairment down the road and that certain symptoms that persist after recovering from the infection may be associated with cognitive decline. One study uncovered ties between persistent loss of smell after recovering from COVID-19 and cognitive decline. The other found that people whose physical and respiratory health suffered due to a bout of COVID-19 were more likely to have issues with cognition afterward. “I think what we’re learning is that it’s quite possible that these COVID-19 infections are potentially having an impact on the brain in some way,” says Rebecca Edelmayer, PhD, who is the senior director of scientific engagement for the Alzheimer’s Association in Chicago. Edelmayer was not affiliated with either study.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.